Certain people are prone to keloids, a type of raised scar caused by dysfunctional wound healing, and want to know how to get rid of them. Surgery is an option, but for those unable or unwilling to ...

Jan. 15, 2025 — Researchers have designed process that uses ultrasound to modify the behavior of cancer-fighting T cells by increasing their cell permeability. They targeted freshly isolated ...

Sensus Healthcare, Inc.’s SRTS share price has dipped by 32.37%, which has investors questioning if this is right time to buy ...

Purpose: The objective of this study is to investigate the clinical efficacy of sequentially comprehensive treatment based on surgery and to furnish clinical evidence for the management of keloids.

Ritlecitinib is under clinical development by Pfizer and currently in Phase II for Keloids. According to GlobalData, Phase II drugs for Keloids does not have sufficient historical data to build an ...

Compression techniques, also known as pressure therapy, can help to speed up the wound healing process and prevent scars from forming or getting bigger, especially keloid scars. Compression sock ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

The device delivers ultrasound energy to the patient’s pancreas and generates localized heat of up to 100 degrees Celsius that destroys cancer cells in the organ. Other types of ultrasound waves ...

The skin, being a multifaceted organ, performs a pivotal function in the complicated wound-healing procedure, which encompasses the triggering of several cellular entities and signaling cascades.

Lake Street Capital started coverage on shares of Sensus Healthcare (NASDAQ:SRTS – Free Report) in a research report released on Friday, Ratings reports. The firm issued a buy rating and a $18.00 ...